相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies
Mihalis S. Kariolis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
Samuel H. Myers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The influence of subclonal resistance mutations on targeted cancer therapy
Michael W. Schmitt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT
D. N. Debruyne et al.
ONCOGENE (2016)
Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase
Stanley G. Kimani et al.
CELL COMMUNICATION AND SIGNALING (2016)
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
R. B. Birge et al.
CELL DEATH AND DIFFERENTIATION (2016)
Efferocytosis
Sushil Kumar et al.
CURRENT BIOLOGY (2016)
TAM Receptor Signaling in Immune Homeostasis
Carla V. Rothlin et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Moshe Elkabets et al.
CANCER CELL (2015)
Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis
Amanda Kirane et al.
CANCER RESEARCH (2015)
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Toni M. Brand et al.
CLINICAL CANCER RESEARCH (2015)
AXL as a modulator of sunitinib response in glioblastoma cell lines
Olga Martinho et al.
EXPERIMENTAL CELL RESEARCH (2015)
Avalanche for shape and feature-based virtual screening with 3D alignment
David J. Diller et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2015)
Biology of Zika Virus Infection in Human Skin Cells
Rodolphe Hamel et al.
JOURNAL OF VIROLOGY (2015)
Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia
I-K Park et al.
LEUKEMIA (2015)
Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status
Christopher T. Cummings et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
Alisa B. Lee-Sherick et al.
ONCOTARGET (2015)
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells
Nitu Bansal et al.
ONCOTARGET (2015)
Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib
Shengzhi Xie et al.
ONCOTARGET (2015)
BGB324, a selective small molecule Axl kinase inhibitor to overcome EMT-associated drug resistance in carcinomas: Therapeutic rationale and early clinical studies
Katarzyna Wnuk-Lipinska et al.
CANCER RESEARCH (2014)
AXL Mediates Resistance to Cetuximab Therapy
Toni M. Brand et al.
CANCER RESEARCH (2014)
Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
Khanh-Quynh N. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
Wen-I Tsou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Magdalena Paolino et al.
NATURE (2014)
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
Mihalis S. Kariolis et al.
NATURE CHEMICAL BIOLOGY (2014)
Diversification of TAM receptor tyrosine kinase function
Anna Zagorska et al.
NATURE IMMUNOLOGY (2014)
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
M. K. Asiedu et al.
ONCOGENE (2014)
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Erinn B. Rankin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer
Christopher T. Cummings et al.
ONCOTARGET (2014)
MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
Kristina H. Knubel et al.
ONCOTARGET (2014)
Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity
Stanley Gititu Kimani et al.
FRONTIERS IN IMMUNOLOGY (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia
Rachel M. A. Linger et al.
BLOOD (2013)
Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer
Wonjun Ji et al.
BMC CANCER (2013)
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
Rebecca S. Cook et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MERTK receptor tyrosine kinase is a therapeutic target in melanoma
Jennifer Schlegel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer
Justin F. Gainor et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Keith M. Giles et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
R. M. A. Linger et al.
ONCOGENE (2013)
The TIM and TAM Families of Phosphatidylserine Receptors Mediate Dengue Virus Entry
Laurent Meertens et al.
CELL HOST & MICROBE (2012)
ZINC: A Free Tool to Discover Chemistry for Biology
John J. Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia
Jing Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Elevated plasma gas6 levels are associated with venous thromboembolic disease
Mark D. Blostein et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Targeting Axl and Mer Kinases in Cancer
Anupam Verma et al.
MOLECULAR CANCER THERAPEUTICS (2011)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization
J. M. E. M. Cosemans et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
Amy K. Keating et al.
MOLECULAR CANCER THERAPEUTICS (2010)
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
X. Ye et al.
ONCOGENE (2010)
Identifying and Characterizing Binding Sites and Assessing Druggability
Thomas A. Halgren
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells
Heather M. Seitz et al.
JOURNAL OF IMMUNOLOGY (2007)
Role of the growth arrest-specific gene 6 (gas6) product in thrombus stabilization
Francois Saller et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Structural basis for Gas6-Axl signalling
T Sasaki et al.
EMBO JOURNAL (2006)
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites
ATR Laurie et al.
BIOINFORMATICS (2005)
Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses
WR Gould et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
ZINC - A free database of commercially available compounds for virtual screening
JJ Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells
MK Callahan et al.
JOURNAL OF IMMUNOLOGY (2003)
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family
QX Lu et al.
SCIENCE (2001)
The effect of lipid composition and physical state of phospholipid monolayer on the binding and incorporation of a basic amphipathic peptide from the C-terminal region of the HIV envelope protein gp41
D Trommeshauser et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
分享论文
